These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27815596)

  • 1. Targeting the energy guardian AMPK: another avenue for treating cardiomyopathy?
    Li T; Jiang S; Yang Z; Ma Z; Yi W; Wang D; Yang Y
    Cell Mol Life Sci; 2017 Apr; 74(8):1413-1429. PubMed ID: 27815596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells.
    Chang W; Zhang M; Meng Z; Yu Y; Yao F; Hatch GM; Chen L
    Eur J Pharmacol; 2015 Dec; 769():55-63. PubMed ID: 26522928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice.
    Xie Z; Lau K; Eby B; Lozano P; He C; Pennington B; Li H; Rathi S; Dong Y; Tian R; Kem D; Zou MH
    Diabetes; 2011 Jun; 60(6):1770-8. PubMed ID: 21562078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
    Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldolase promotes the development of cardiac hypertrophy by targeting AMPK signaling.
    Li Y; Zhang D; Kong L; Shi H; Tian X; Gao L; Liu Y; Wu L; Du B; Huang Z; Liang C; Wang Z; Yao R; Zhang Y
    Exp Cell Res; 2018 Sep; 370(1):78-86. PubMed ID: 29902536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms.
    Saeedi R; Parsons HL; Wambolt RB; Paulson K; Sharma V; Dyck JR; Brownsey RW; Allard MF
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2497-506. PubMed ID: 18375721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPK and cardiac remodelling.
    Feng Y; Zhang Y; Xiao H
    Sci China Life Sci; 2018 Jan; 61(1):14-23. PubMed ID: 29170891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation.
    Daskalopoulos EP; Dufeys C; Bertrand L; Beauloye C; Horman S
    J Mol Cell Cardiol; 2016 Feb; 91():188-200. PubMed ID: 26772531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin attenuates pressure overload-induced cardiac hypertrophy via AMPK activation.
    Fu YN; Xiao H; Ma XW; Jiang SY; Xu M; Zhang YY
    Acta Pharmacol Sin; 2011 Jul; 32(7):879-87. PubMed ID: 21552292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sitagliptin attenuates myocardial apoptosis via activating LKB-1/AMPK/Akt pathway and suppressing the activity of GSK-3β and p38α/MAPK in a rat model of diabetic cardiomyopathy.
    Al-Damry NT; Attia HA; Al-Rasheed NM; Al-Rasheed NM; Mohamad RA; Al-Amin MA; Dizmiri N; Atteya M
    Biomed Pharmacother; 2018 Nov; 107():347-358. PubMed ID: 30099338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis.
    Hinson JT; Chopra A; Lowe A; Sheng CC; Gupta RM; Kuppusamy R; O'Sullivan J; Rowe G; Wakimoto H; Gorham J; Burke MA; Zhang K; Musunuru K; Gerszten RE; Wu SM; Chen CS; Seidman JG; Seidman CE
    Cell Rep; 2016 Dec; 17(12):3292-3304. PubMed ID: 28009297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exendin-4 attenuates cardiac hypertrophy via AMPK/mTOR signaling pathway activation.
    Zhou Y; He X; Chen Y; Huang Y; Wu L; He J
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):394-9. PubMed ID: 26519882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.
    Zhang CX; Pan SN; Meng RS; Peng CQ; Xiong ZJ; Chen BL; Chen GQ; Yao FJ; Chen YL; Ma YD; Dong YG
    Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):55-62. PubMed ID: 21083698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted deletion of PTEN in cardiomyocytes renders cardiac contractile dysfunction through interruption of Pink1-AMPK signaling and autophagy.
    Roe ND; Xu X; Kandadi MR; Hu N; Pang J; Weiser-Evans MC; Ren J
    Biochim Biophys Acta; 2015 Feb; 1852(2):290-8. PubMed ID: 25229693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calhex₂₃₁ Ameliorates Cardiac Hypertrophy by Inhibiting Cellular Autophagy in Vivo and in Vitro.
    Liu L; Wang C; Sun D; Jiang S; Li H; Zhang W; Zhao Y; Xi Y; Shi S; Lu F; Tian Y; Xu C; Wang L
    Cell Physiol Biochem; 2015; 36(4):1597-612. PubMed ID: 26159880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid excess induces accumulation of cardiac glycogen and triglyceride: suggested role for AMPK.
    Puthanveetil P; Rodrigues B
    Curr Pharm Des; 2013; 19(27):4818-30. PubMed ID: 23323614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMP-activated protein kinase: a core signalling pathway in the heart.
    Kim AS; Miller EJ; Young LH
    Acta Physiol (Oxf); 2009 May; 196(1):37-53. PubMed ID: 19239414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation in the γ2-subunit of AMP-activated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage.
    Kim M; Hunter RW; Garcia-Menendez L; Gong G; Yang YY; Kolwicz SC; Xu J; Sakamoto K; Wang W; Tian R
    Circ Res; 2014 Mar; 114(6):966-75. PubMed ID: 24503893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transitory activation of AMPK at reperfusion protects the ischaemic-reperfused rat myocardium against infarction.
    Paiva MA; Gonçalves LM; Providência LA; Davidson SM; Yellon DM; Mocanu MM
    Cardiovasc Drugs Ther; 2010 Feb; 24(1):25-32. PubMed ID: 20229055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases.
    Lu Q; Li X; Liu J; Sun X; Rousselle T; Ren D; Tong N; Li J
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30710062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.